Trials / Completed
CompletedNCT06326931
Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction
A Prospective, Randomized Comparison of Thermal Pulsation Versus Warm Compress Treatment for Signs and Symptoms of Meibomian Gland Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Jacksoneye · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to assess the treatment outcome differences between a single, in-office bilateral treatment with the thermal pulsation system and twice-daily, 10-minute applications of the warm compress mask at home for 8 weeks.
Detailed description
This prospective, single-center, single-masked, randomized, controlled clinical trial compared the Systane iLux handheld thermal pulsation system with a warm compress mask (Bruder Moist Heat Eye Compress, Bruder Healthcare, Alpharetta, GA, USA) for the treatment of meibomian gland dysfunction (MGD). Subjects aged 18 or older were randomized 1:1 to either a single in-office thermal pulsation treatment or twice-daily use of the warm compress mask, with both eyes undergoing the same treatment. Enrollment criteria included Ocular Surface Disease Index (OSDI) score \>23, total meibomian gland secretion (MGS) score \< or =12 in the lower lid of each eye, and tear break-up time (TBUT) \< 10 seconds. TBUT, MGS, and corneal staining scores were evaluated at baseline, 2 weeks, and 8 weeks. Symptoms were evaluated using the OSDI questionnaire at baseline, 2 weeks, and 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | thermal pulsation | Single, in-office bilateral treatment with Systane iLux thermal pulsation |
| OTHER | warm compress | Twice daily, 10-minute at-home treatment with Bruder warm compress mask for 8 weeks |
Timeline
- Start date
- 2022-06-24
- Primary completion
- 2023-06-22
- Completion
- 2023-06-22
- First posted
- 2024-03-22
- Last updated
- 2024-03-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06326931. Inclusion in this directory is not an endorsement.